We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Protector Sheet Promotes Tendon Healing

By HospiMedica staff writers
Posted on 05 Mar 2007
A new tendon protection sheet aids in the management and protection of tendon injuries in which there has been no substantial loss of tendon tissue.

The TenoGlide tendon protector sheet is an advanced tendon protection device, composed of a porous matrix of cross-linked collagen and glycosaminoglycan (GAG), and is designed to serve as an interface between the tendon and the surrounding tissues. More...
The collagen-GAG resorbable matrix provides a protective, biocompatible interface, which creates a favorable environment and gliding surface for tendon healing. Since tendon and peripheral nerve injuries often occur together, the protector sheet can be used in conjunction with two other products from the same manufacturer: the NeuraGen nerve guide for completely transected nerves, and the NeuraWrap nerve protector for nerve injuries, which include compressed or scarred nerves. The single-use product is supplied sterile and non-pyrogenic, in double peel packages in a variety of sizes.

The TenoGlide Tendon Protector Sheet is manufactured by Integra LifeSciences (Plainsboro, NJ, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"In our pre-clinical studies, the data indicate that the use of TenoGlide Tendon Protector Sheet during tendon repair in an animal model significantly reduced formation of scar tissue between the tendon and surrounding tissue, as compared to untreated controls,” said Mayer Tenenhaus M.D., FACS, associate clinical professor of surgery/plastic
surgery at the University of California, San Diego (UCSD, USA).


Related Links:
Integra LifeSciences
University of California

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.